• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Winthrop P. Rockefeller Cancer Institute: UAMS Myeloma Center
  • UAMS Health
  • Jobs
  • Giving
  • About
    • Our Collaborations
    • Our History
    • Why Choose Us?
    • Calendar of Events
  • Patient Care
  • Research
  • Resources
    • Myeloma Magazine
    • Video Library
  • Contact

Myeloma Center

Learn more about Diagnosis & Treatment

Why Choose Us?

The UAMS Myeloma Center is an international leader in the treatment and study of multiple myeloma and related diseases.

About the Myeloma Center

Important Links

Appointments

Contact our Intake Office for an appointment.

Make an Appointment

Our Myeloma Doctors

We have expertise in the treatment of multiple myeloma.

Meet the Providers

Patient Care

We are known for our “bench to bedside” approach.

Patient Care

Clinical Trials

We are committed to offering a program of clinical trials.

Find a Clinical Trial

UAMS Myeloma Center

The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.

Total Therapy Approach

At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.

Learn more

Winter 2024/2025 Myeloma Magazine

The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.

Read Magazine

Meet the Myeloma Center

Meet the Myeloma Center with Dr. Carolina Schinke.

Watch the Video

Myeloma Center: Looking Toward the Future: Myeloma Center Celebrates 35th Anniversary

The Myeloma Center, located in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), has firmly established itself as an international leader in myeloma treatment. From its beginnings in 1989, UAMS’ myeloma program is recognized for detailed patient care, groundbreaking research and pioneering advances in the management of myeloma…

Read more

News & Announcements

Jeff and Leigh Ann Williams.

24-Year Myeloma Survivor Cites Positive Attitude as Key to Longevity

Jeff Williams maintains a basic approach to living with multiple myeloma. “Get as much exercise as possible,” he said. “I work about a mile from a YMCA. I stay in shape. It has to be a habit. If you go long enough, it will become a habit. Resistance training builds bone density.” Williams, 66, is…

Read more
Zhan

UAMS Invests Fenghuang “Frank” Zhan, M.D., Ph.D., in Inaugural Barlogie Chair for Myeloma Research

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Fenghuang “Frank” Zhan, M.D., Ph.D., a tenured professor of medicine and the research director of the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, in the Dr. Bart Barlogie Chair for Myeloma Research during a March 13 ceremony. Zhan is…

Read more
Wanchai and Zhang

Behind the Scenes

Visanu Wanchai, Ph.D. Visanu Wanchai, Ph.D., is a postdoctoral fellow with the UAMS College of Medicine. He earned his doctorate in biomedical informatics from UAMS in 2020 and joined the Myeloma Center in 2022. His focus is developing leading-edge computational tools and employing high-performance computing techniques for  single cell analysis to investigate key genes and…

Read more
Sun, Cheng, Schninke

Publications

Bispecific BCMA/CD24 CAR T cells control multiple myeloma growth Nature Communications January 2024 Primary authors: Fumou Sun, Ph.D.; Yan Cheng, Ph.D. Anti-multiple myeloma B cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapies represent a promising treatment strategy with high response rates in myeloma. However, durable cures following anti-BCMA CAR T-cell treatment of myeloma…

Read more

Want to read more stories like these?

View the Full List
Winthrop P. Rockefeller Cancer Institute LogoWinthrop P. Rockefeller Cancer InstituteWinthrop P. Rockefeller Cancer Institute
Address: 449 Jack Stephens Dr., Little Rock, AR 72205
Parking Deck: 4018 W Capitol Ave., Little Rock, AR 72205
New Appointments: (501) 686-7105
Information Line: (501) 804-3557
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences